Chemed Corp (CHE) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Chemed Corp (CHE) stock forecast summary
On Oct. 16, 2026, CHE is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5172 stocks scored that day.
Chemed Corp is a mid-cap company with a market capitalization of $6.70B. It ranks number 2 by market capitalization among the 6 Services-Home Health Care Services issuers in our coverage with a current forecast.
For CHE, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 56.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 19.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CHE included.
Follow CHE freeCHE price chart and AI forecast
How CHE ranks among 5172 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Chemed Corp (CHE) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Home Health Care Services peers listed below that report each metric.
Valuation & Market
| Metric | CHE | Rank |
|---|---|---|
| Market Cap | $6.70B | 2/6 |
| P/E Ratio | 25.77x | 2/5 |
| P/B Ratio | 8.06x | 2/6 |
| Dividend Yield | 0.50% | – |
| EPS | $19.88 | – |
| Book Value/Share | $63.54 | – |
| Revenue/Share | $198.55 | – |
| FCF/Share | $24.76 | – |
Profitability & Margins
| Metric | CHE | Rank |
|---|---|---|
| ROE | 33.1% | 2/5 |
| ROA | 17.4% | 2/6 |
| ROIC | 27.7% | 1/6 |
| Gross Margin | 33.1% | 2/6 |
| Operating Margin | 13.5% | 1/6 |
| Net Margin | 10.6% | 1/5 |
| EBT Margin | 14.2% | 1/6 |
| Tax Rate | 25.5% | – |
Financial Health
| Metric | CHE | Rank |
|---|---|---|
| Current Ratio | 0.91x | 6/7 |
| Quick Ratio | 0.89x | – |
| D/E Ratio | 0.90x | 5/6 |
| Financial Leverage | 1.90x | 5/6 |
| Interest Coverage | 49.9x | 1/7 |
| Working Capital | -$29M | 7/7 |
Cash Flow
| Metric | CHE | Rank |
|---|---|---|
| Operating Cash Flow | $390M | 3/7 |
| Free Cash Flow | $324M | 2/5 |
| Capital Spending | -$66M | 3/5 |
| OCF Growth YoY | -8.6% | 5/6 |
| FCF Growth YoY | -12.9% | 3/5 |
| FCF/Sales | 12.5% | 1/5 |
| CapEx/Sales | 2.6% | 2/5 |
Operational Efficiency
| Metric | CHE | Rank |
|---|---|---|
| Asset Turnover | 1.64x | 3/5 |
| Receivables Turnover | 13.8x | 1/5 |
| Inventory Turnover | 227.5x | – |
| Fixed Assets Turnover | 12.4x | 4/5 |
| Days Sales Outstanding | 27 days | 5/5 |
| Days Inventory | 2 days | – |
| Payables Period | 18 days | 3/5 |
| Cash Conversion Cycle | 10 days | – |
Income Statement
| Metric | CHE | Rank |
|---|---|---|
| Total Revenue | $2.60B | 4/5 |
| Operating Income | $349M | 2/7 |
| Net Income | $275M | 1/6 |
| SG&A Expense | $441M | – |
| Cost of Goods Sold | $1.74B | 4/5 |
Dividend & Shareholder Information
| Metric | CHE | Rank |
|---|---|---|
| Dividends Per Share | $2.54 | – |
| Payout Ratio | 12.8% | – |
| Shares Outstanding | 13M | – |
| Net Income Growth | -5.3% | 4/5 |
| EPS Growth | 2.3% | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $291M | 18.4% of assets |
| Cash & Short-term Investments | $40M | 2.5% of assets |
| Accounts Receivable | $189M | 11.9% of assets |
| Inventory | $8M | 0.5% of assets |
| Total Liabilities | $749M | 47.4% of assets |
| Short-term Debt | $235M | 14.9% of assets |
CHE quarterly financials and insider trading
Chemed Corp (CHE) industry peers
Companies classified under the same SEC industry code as Chemed Corp (Services-Home Health Care Services): 7 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere CHE sits on the market map
Chemed Corp (CHE) stock news
Loading...
Chemed Corp (CHE) stock forecast FAQ
What is the Chemed Corp (CHE) stock forecast?
On Oct. 16, 2026, CHE is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5172 stocks scored that day.
How accurate are Chemed Corp stock predictions?
For CHE, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 56.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 19.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Chemed Corp forecasts updated?
Chemed Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Chemed Corp's industry peers?
7 issuers in our coverage, CHE included, share the SEC industry code Services-Home Health Care Services. The largest are: Brightspring Health Services, Inc. (BTSG), Option Care Health, Inc. (OPCH), Aveanna Healthcare Holdings, Inc. (AVAH), Addus Homecare Corp (ADUS), Adapthealth Corp. (AHCO), Edgemode, Inc. (EDGM).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.